Institutional Ownership
Cumberland Pharmaceuticals I
CUSIP 230770109COMCPIXQ1 2026
13D / 13G Filings
19
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
40.8%
Max % of class reported
Institutional Holders
27
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
19 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | A.J. Kazimi | 13G | 38.4% | 5.79M | SEC |
| 2 | Oct 30, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 598.6K | SEC |
| 3 | May 15, 2025 | Ikarian Capital, LLC | 13G | 11.0% | 730.9K | SEC |
| 4 | Apr 24, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 809.9K | SEC |
| 5 | Feb 13, 2025 | A.J. Kazimi | 13G | 40.8% | 5.70M | SEC |
| 6 | Feb 11, 2025 | Integrated Core Strategies (Us) LLC | 13G | 11.0% | 1.23M | SEC |
| 7 | Feb 9, 2024 | Cumberland Pharmaceuticals Inc | 13G | 40.1% | 5.72M | SEC |
| 8 | Feb 10, 2023 | Kazimi A J | 13G | 39.4% | 5.75M | SEC |
| 9 | Feb 14, 2022 | Kazimi A J | 13G | 38.3% | 5.77M | SEC |
| 10 | Feb 8, 2022 | Dimensional Fund Advisors LP | 13G/A | 4.4% | 652.6K | SEC |
9 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cumberland Pharmaceuticals I.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 553.2K | $1.80M |
| 2 | Renaissance Technologies LLC | 470.7K | $1.53M |
| 3 | Dimensional Fund Advisors LP | 276.4K | $898.2K |
| 4 | Perceptive Advisors LLC | 197.0K | $640.2K |
| 5 | Bridgeway Capital Management, LLC | 163.5K | $531.3K |
| 6 | Boothbay Fund Management, LLC | 127.7K | $415.0K |
| 7 | Geode Capital Management, LLC | 114.3K | $371.5K |
| 8 | J. Goldman & Co LP | 81.0K | $263.4K |
| 9 | Bank Of New York Mellon Corp | 58.5K | $190.0K |
| 10 | Blackrock, Inc. | 56.9K | $184.9K |